Sedat Evran - 20 Oct 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Global Supply Chain
Signature
/s/ Sedat Evran
Issuer symbol
BIO
Transactions as of
20 Oct 2024
Net transactions value
-$116,034
Form type
4
Filing time
22 Oct 2024, 16:30:03 UTC
Previous filing
10 Sep 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1,044 +724% $0.000000 1,188 20 Oct 2024 Direct F1, F2
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $116,034 -335 -28% $346.37 853 20 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1,044 -25% $0.000000 3,132 20 Oct 2024 Bio-Rad A Common Stock 1,044 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 49.0480, 41.3870 and 33.7050 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2023, 03/31/2024 and 06/30/2024, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.